Zacks Upgrades and Revisions Strategy highlights: American Physicians Capital, CompuCredit Corp., Cantel Medical Corp. and Florida Rock Industries.

CHICAGO -- Earnings estimate revisions are the most powerful force impacting stock prices. Couple that with the proven benefits of upgrades in ratings from brokerage firms and you have a strategy that delivered a +55.7% return in 2004. In 2005, the Upgrades and Revisions Profit Track continued its trend of delivering double-digit returns by returning 27% compared to the S&P 500 return of 4.9%. Four stocks meeting this screen's exclusive criteria are: American Physicians Capital, Inc. (Nasdaq: ACAP), CompuCredit Corp. (Nasdaq: CCRT), Cantel Medical Corp. (NYSE: CMN) and Florida Rock Industries, Inc. (NYSE: FRK). View the entire list of stocks for the Upgrades and Revisions Profit Track at http://at.zacks.com/?id=1844

Here are details on four companies currently identified by the Upgrades and Revisions Profit Track:

American Physicians Capital, Inc. (Nasdaq: ACAP) is a holding company for several entities, including both insurance and financial services companies. The company delivered earnings per share growth of 266% over the past five years. In late April, ACAP posted first-quarter earnings of $1.05 per share. The result topped the consensus estimate by about 19% and outperformed the year-ago total.

CompuCredit Corp. (Nasdaq: CCRT) announced first-quarter managed earnings of $1.09 per share in early May. The result outperformed the consensus estimate by roughly 18% and beat the year-ago total. The company commented that it delivered excellent results in the first quarter with high return on assets, historically low losses, and strong new customer account growth. CCRT has experienced earnings growth of 49% during the past five years.

Cantel Medical Corp. (NYSE: CMN) has seen earnings per share growth of 22% during the past five years. The company recently reported fiscal third-quarter earnings or 28 cents per share, eclipsing the consensus estimate by 12% and surpassing the previous year's 23 cents. Sales advanced 29% year-over-year. Cantel Medical Corp. is a healthcare company concentrating primarily in infection prevention and control products.

Florida Rock Industries, Inc. (NYSE: FRK), a Zacks #1 Rank (Strong Buy) company, released fiscal second-quarter earnings of 86 cents per share in late April. The result outpaced analysts' expectations by nearly 39% and improved year-over-year. The company said its quarterly results benefited from improved weather, pricing and demand in substantially all of its markets. FRK satisfies the criteria for this Profit Track as evidenced by its earnings per share growth of 27% over the past five years.

Discover all the current stocks currently on the Upgrades and Revisions Profit Track at: http://at.zacks.com/?id=1869

About Profit Tracks

What is a "Profit Track"? Each Profit Track is a successful stock picking strategy with proven results through the Bear Market of 2001-2002 and the Bull run started in 2003. On Zacks.com we have created these nine unique screens to offer investors great strategies to potentially outperform the market in the years ahead. In 2005, the Low Price Stocks strategy was the top performing Profit Track with a return of +51.9% followed by the Recent Price Strength screen with a +35.5% return. To see all nine strategies along with philosophy, past performance, and current stocks, go to http://at.zacks.com/?id=1838

All the Profit Track strategies were created and backtested using the Research Wizard software from Zacks Investment Research. If you like this screening strategy, but want to narrow down the list of stocks and even improve the performance, then you should start a free trial to this powerful stock picking tool. Learn more about the Research Wizard free trial offer and our new special report "Top 10 Stock Screening Strategies" at http://at.zacks.com/?id=2156

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=1841

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

(a) The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard and Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs, and represents the gross returns before management fees.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.